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1.

INTRODUCTION
The ordinary layman is frightened by the drama�ic
loss of blood from open wounds, but the ordinary physi
cian understands the cause and can calmly meet the de
mands of the situation.

Much more terrifying to the phy

sician is the undramatic, slow, relentless loss of blood
in hemorrhagic diathesis.

When the cause of the hemor

rhage is unknown it is even more_ fearful because lack of
therapeutic means may mean loss of the patient's life.
During the past.century and longer, physicians and
surgeons have stood by and watched this mysterious and
alarming hemorrhagic diathesis take the lives of many of
their jaundiced patients.

Theories advanced t? explain

the condition had that peculiarly impotent character
which theories concerning hopeless matters usually have.

Various therapeutic measures against it were mentioned
with reticence which marks most inefficacious measures.

In the last few years new knowledge has come to dis�
pel some of the old fears.

Researchers and clinicians

have followed numerous lines of inquiry finally to con
verge and form one coherent theory concerning the real
cause of bleeding in jaundice and certain allied condi
tions.

Along with this theory has come the discovery

of a substance that acts almost as a specific• preventa-
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tive of the hemorrhagic tendency in these various con
ditions.
The aim of this paper is to show that a substance
called Vitamin K has veen discovered, scientifically
studied, and clinically proven to be of value in cer
tain hemorrhagic conditions, and that the theory of its
action fits logically into the theory developed as to
the cause of the various hemorrhagic conditions in which
this substance is of value.

The story of vitamin K will

be considered more or less from the historical point of
view with a rather comprehensive review of the literature
included.

Emphasis will be placed on the present status

of the vitamin both clinically and experimentally.

3.

HISTORICAL
The existence of vitamin K was first suspected by
Dam of Copenhagen in 1929 (29).

While working on some

studies of sterol metabolism in newly hatched chicks on
a fat free diet, which consisted of vitamin A free case1nogen 20 parts, marmite 10 parts, soluble starch 65.5
parts, salts 4.5 and varying amounts of cod-liver oil,
it was noted that the chicks had a tendency to large sub
cutaneous and intramuscular hemorrhages and certain path
ological changes in the walls of the stomach.
in the animals was subnormal.

The t!:rowth

The low content o� fat and

cholesterol was found to be of no importance, because addi
tion of cholesterol and cod-liver oil did not prevent the
symptoms.
This work prompted further experiments al��

� �s

same line; and in 1934 Dam and Schonheyder (3) reported
that chicks, kept on a basal diet essential-- si...!lar to
the one listed above, developed a syndrome tl:a.t resembles
scurvy:

tendency to large hemorrhages, ede�, and hyper

plastic inflammatory changes in the 1w1c s membrane of the
gizzard, anemia, and lack of growth.

The hemorrhagic con

dition occurred ten to fifteen days after beginning the
diet.

The condition was not relieved by the addition of

ascorbic acid to the diet.

In adding various substances
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to the�diet they found that certain cereals seem to co tain a factor that relieves the symptoms.
In 1935 Schonheyder (83) showed that the chicks on
the deficiency diets that showed the hemorrhagic tenden
cy have a decreased clotting time of the blood.

This

same year Dam (31) summarized the work done to date and
described further experiments on newly hatched white leg
horns which were kept on a basal defieiency diet for a
month.

Clotting time was determined; then the chicks

were killed �d the organs examined for hemorrha�es •
. Various foods were added to the diets, and it was found
that some seeds and cereals are effective and some not,
some vegetables as tomatoes and kale will prevent the
hemorrhages, extracts of animal organs are of value,
with ether extracted hog liver appearing as a most pc
tent source.

Egg yolk is of some value.

Large amounts

of vitamins A and D do not prevent the disease.
tor is apparently destroyed by heat.

ne fac

Comparison of the

weit;:ht curves in the various series of chicks on the de
ficiency and non-deficient diet indicate that the anti
hemorrhagic factor does not promote

0 rowth:

��e sub

stance is thought to resem'le vitamin � chemically, but
it is not found in wheat
tent source of vitamin::::.

er

oil which is the most po

Dam named this antihemorrhagic

factor vitamin K, referring to the german term

t1 Koagula-
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tions" vitamin.
Schonheyder (83) pointed out that there are marked
differences in clotting time under the same conditions in
the plasma of sick and normal chicks.

The plasma of a

sick chick will become normal in a few days by adding su
fficient vitamin K to the diet.

There appears to be no

morphological changes in the blood or in the fibrinogen
or calcium content.

Thrombokinase is not reduced, and

there is no increase in antithrombin.

Inv�stigations

have shown that in normal plasma a component is present
which accelerates the clotting time over that of the sick
animal.

It is supposed that a lack of vitamin K causes

a decrease of •the clotting accelerating component in the
blood.
Another condition pertaining to the .sB.?1-e problem of
�emorrhagic diathesis was reported by Roderick (81) in
1931 who made a study of "Sweet Clover" disease in cattle.
The feedint;: of damaged sweet clover hay and silage to
cattle results in losses whereby the animals die of hem
orrhage which is preceded by a characteristic delay in
the coagulation of the blood •

.Analytical work on a se

ries of animals showed the fibrinogen of the blood to be
within normal limits.

The work indicates that the de

layed coagulability involves a reduction in the prothrom
bin and that the dimlnution parallels the delay in coagu-
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lation time.

There is no evidence of an increase ��

inhibitory factor like heparin or antithrombin.
calcium is within normal limits.

E:ooo

The decrease in pro

thrombin is independent of the- number of platelets ·,·:1-'...!.ch
remains normal until hemorrhage occurs.

He found that

the condition could be treated by transfusion with normal
bovine blood.
In 1937 Quick (74) reported on the _same disease in
rabbits fed experimentally on spoiled sweet clover.

He

noted a drop in plasma prothrombin and the hemorrhagic
tendency.

Transfusion gives marked beneficial ·effect,

but the elevation of the'prothrombin is of short dura
tion.

Injection of defibrinated blood has little effect.

The incorporation of 5% alfalfa with the toxic hay, suc
cessfully prevents the development of the disease; and a
small quantity of dehydrated alfalfa meal will cure the
condition by elevating the prothrombin to normal levels.
The theory is presented that the spoiled hay contains a
toxic principle which either destroys the prothrombin

r

inhibits the mechanism by which the body produces t �s
clotting factor, and that alfalfa exerts its curati�e
effect by supplying an accessory food factor re · red
by the organism for the synthesis of prothrombin.

The

possibility is presented that the hemorrhagic diathesis
met with incertain cases of obstructive �aundice may be
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due to a de�iciency of the vitamin required by the body
for the production of prothrombin.
In 1936 Hawkins and Brinkhous (49), in their study
of dogs with complete biliary fistula maintained on a
normal diet, found a lengthening of clotting time dev
eloping in three to five months.

They found a low pro

thrombin time by the Warner and Brinkhous prothrombin
titration method.

If adequate whole dog bile was fed

the clotting time remained normal.

The hemorrhagic ten

dency does not develop unless the prothrombin level is
very low.
Greaves and Schmidt (45) in 1937 were doing various
experiments on bile-fistula rats.

They reported that the

rats showed a loss in blood coagulability and a decrease
The prothrombin level was reduced

in prothrombin level.

to 20% - 30% of normal before the coagulation time was
markedly increased.

There was no evidence of liver dam

age, and the condition could be relieved by the adi:d.nis
tration of vitamin K concentrate.

In 19�9 they re-ortea

(46) that bile salts are essential to intestinal absorn
tion of vitamin Kin the rat.

The bile salts when admin-

istered to animals raised on a vitaminK

free diet are

much less efficient than when administere

along with

vitamin Kconcentrates.

Greaves and Schmi t (47) in March

1939 described their experiments in detail and
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'pointed out the later finding that bile fistula, jaundi-'
ced, or normal rats raised for extended periods of time
on a vitamin K free diet still excrete significant amounts
of the vitamin in the feces.

It is pointed out that in

fection and liver damage may also cause a bleeding tenden
cy.

Bile is demonstrated to be a poor source of vitamin

K, and it is shown.that vitamin K is not stored in appre
ciable quantities in the liver of the rat.
The chief source of the vitamin in early experimental
work was alfalfa; then later it had been shown that fish
meal and rice bran which have been exposed to the action
of micro-organisms contain the antihemorrhagic vitamin
and that it is also present in the feces of chicks kept
on a vitamin K free diet.

In 1938 Almquist (4) demon

strated the actual synthesis of the vitamin by growing
bacteria.
media.

Various organisms were cultured on different

The dried bacteria of certain species were found

to have a vitamin K potency five to ten times that of
dried alfalfa.

Some species were found to contain little

or none of the antihemorrhagic factor.

i'his factor can

be extracted from the bacteria by fat solvents, but its
further similarity to vitamin K has not been established.
E. coli, B. aerogenes, and B. subtilis, and S. Aureus are
four species _that show a high content of the antihemor
rhagic factor.
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.Dam (37} in 1938 reported in detail his studies on
the mode of action of vitamin Kin chicks which he had
been working on for several years.

For his experiments

on the chicks he prepared a liquid yellow oil concentrate
of vitamin Kfrom alfalfa and emulsified it by dissolving
it in acetone and adding it to water and then driving off
the acetone.

He found that intravenous injection with

the emulsion rendered the clotting power normal in about
five hours.

Intramuscular administration is effective

but subcutaneous is not.

Leaving emulsions of vitamin

Kin contact with plasma or whole blood from K-avitamin
osis chicks for five hours did not result in improved
clotting time; wherefrom it �s concluded that a tissue
activity is necessary for the development of the effect.
It was demonstrated "that the spleen is not the organ on
which the action of vitamin Kdepends.

Ether anesthesia

and laparotomy had no influence on the clotting time. Mi
- vitamin
croscopic examination of the bone marrow of Ka
osis chicks showed no visible abnormality.

The approxi

mate cont�nt of vitamin Kin organs of chicks fed on di
fferent diets was found to be relatively small.
Schonheyder (85} in 1938 reported that the hemorrha
gic diathesis in chickens produced by a deficiency of vi
tamin Kis due to a decrease in plasma prothrombin.

A

�irect relationship exists between clotting time, concen-
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tration of prothrombin, and the tissue factor.

He also

pointed out that the concentration of prothrombin is the
same in young chicks as that found in the adult birds.
In studying the coagulation defect in jaundiced pa
tients, many theories as to its cause have been sugges
ted.

Quick (71) in 1935 was the first to demonstrate

that the clotting defect is due to a prothrombin defi
ciency.

He also showed that prothrombin concentration

is normal in a study of five cases of hemophilia.

How

ever the use of vitamin Kin jaundiced patients was not
reported for the first time until January 1938 when War
ner (105) and his associates reported its successful use
in restoring the prothrombin time to normal.
Following this early basic experimental work, var
ious clinical applications of vitamin Khave been found,
as will be discussed more iri detail later in this paper.
Also sources of the vitamin will be listed, methods of
assay _described, and the story of the chemical analysis•
and synthesis will be discussed.

Theories as to the mode

of action of vitamin Kand methods of determining its de
ficiency will be described.

11.

SOURCES OF VITAMIN K
Many substances have been found to contain vitamin
K or a similar antihemorrhagic factor.

It is probable

that individuals on normal diets get an adequate supply
of the antihemorrhagic vitamin.

The exact requirements

as to amount have not as yet been determined, but thera
peutic doses used indicate that the daily quantity needed
is small.

However there must be a more or less continuous

supply of the vitamin as there is no indication that the
antihemorrhagic substance is stored in the body.

The list

of substances has been gathered from various workers includ
in� Snell (89), Dam (32) (31), Kugelmass (59}, and others.
Substances with vitamin K activity:
Alfalfa

Cow's milk

Kale

Chick feces

Beef liver

Egg yolk

Oat shoots

Human feces

Breast Milk

Fish meal

Rice bran

Phthiocol

Cabbage

Green leaves

Soy bean oil

E. coli

casein

Hemp seeds

Spinach

B. aerogenes

Carrot tops

Hog liver oil

Tomatoes

B. subtilis

Substances without vitamin K activity:
Carrots

Colostrum

Carotene

Liver extract

Corn

Wheat germ oil

cereals

Mangoes

Egg white

Yeast

Chlorophyll

Potato

Human Bile

Beef serum

Cpd-liver oil

Rice

Lemon juice

Plasma globulin

Rye
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METHODS OF ASSAY FOR VITAMIN K
The original method of assay of substances for ant�
hemorrhagic activity was developed by Dam (4) and his co
workers in 1935.

White leghorns were fed experimental

vitamin K deficiency diets from the day of hatching until
the age of one month.

Clotting time was tested from time

of venipuncture to clot formation.

The chicks were then

killed, the organs examined for evidence of hemorrhage,
and hemoglobin was determined.

Various substances to be

tested were added to the basal diet in groups of newly
hatched chicks, and these were examined at one month and
the antihemorrhagic activity of the substance determined.
In 1936 Dam ( 34) and Schonhe·yder ( 84) outlined a
Curative method of assay for vitamin K.

Blood samples

are taken from chicks which have been on a vitamin K de
ficient diet for at least three weeks and are assumed to
be depleted in vitamin K.

The plasma is diluted with

Ringer's solution and is caused to coagulate by the addi
tion of a sufficient amount of a clotting agent to make
the clotting time normal.

The unknown substan_ce to be

assayed is mixed with the deficient diet, fed to the
chicks, and blood samples are retested for clotting time
after several days.

From this data, the dietary level

of the vitamin K factor is determined.
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In 1938 Dam (36) improved his Curative blood clot
Arterial blood plasma from the

ting method of assay.

chlck is diluted with Ringer's sol�tion and placed in a
micro-test-tube and .05 ml. of tissue extract is added.
The tube is closed, incubated at 39 ° C. and rotated, and
clotting time is noted.

By using a series of different

concentrations of tissue extract it is possible to find
the concentration (k) which produces clotting in three
minutes.

(K) concentration of tissue extract is deter

mined for normal chicks and then for the K-avitaminosis
chicks and compared.

The test substance is then fed to

the vitamin deficient chicks until concentration (K) of
tissue extract is the same �s in normally fed chicks.
From the amount ingested per gram of body weight per day
it is possible to calculate how much of the substance
should be given in order to make the clotting time nor
mal.

This amount of the substance is said to contain

one Curative unit.
muscle.

His tissue extract is made f_rom hen's

A selected dried spinach powder in tablets is

used as the vitamin ·K standard of 500 units per gram.
In his determinations he found that it is impossible to
render the coagulability of the plasma supernormal.
Each worker has established his own definition of
a unit of vitamin K.

Since there is no agreement among

the authors, it is impossible at present to compare the
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vitamin K potencies in any standard unit.

Dam-first de�

fined a unit as the amount of antihemorrhagic factor con
tained -in 2 mg. of a standard dried spinach preparation.
Later he defined the Dam unit of vitamin K as the smallest
amount of a substance which during a certain time can
bring the sick animal to normal with respect to clotting
time.
Almquist and Stokstad (2) at the University of Cal
ifornia in 1935 described the Preventative method of assay
which was slightly revised by Almquist and Klose (8) in
Newly hatched leghorn chicks are divided into two

1939.

groups, one of which is �iven a K-avitaminosis diet and
the other group the same diet plus the substance being
tested.

After a few days the clotting time of the two

groups is compared.

In this way the percentage of vita

min K necessary to maintain coagulation time can be de
termined.

In their later tests they used the prothrombin

time test of Quick along with the simple coagulation time
determination.

It was found that the reciprocal of the

mean blood clotting time and the mean prothrombin time
bears a linear relation to the logarithm of the vitamin
K level in the diet over a practical range of levels.
None of the methods of assay that have .been devel
oped are very good except for rather rough determina
tions as to the presence or absence of the vitamin in
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various substances.
,Ansbacher (12) in 1939 outlined a more rapid method
of quantitative assay of vitamin K than the Danish me
thods. · Instead of the usual three day test, he noted
that the blood ciotting power of the vitamin K deficient
chick can be rendered normal in a few hours.

He uses

day old lebhorns kept on a basal K deficient diet for
seven days.

As soon as the chick shows the hemorrhagic

syndrome, the test substance is �iven orally by pipette
and introduced directly into the crop of the chick.

The

He defines a

clotting time is determined in six hours.

unit of vitamin K as a minimum amount necessary to ren
der the blood clotting time of the vitamin K deficient
chick weighing 70 - 100 grams normal within six hours
after administration.

Usually five chicks are used on

one test substance, and the clotting time in six hours
should be reduced to below one half minute.
Dann (39) of the Abbott laboratory in 1939 outlined
a quantitative bio�ogical assay for vitamin K compounds.
The standard used is a vitamin K oil concentrate prepared
from alfalfa.

Chicks are kept on a K-avitaminosis diet

until they are depleted of the vitamin.

Then twenty are

placed on a diet with a definite amount of the unknown
and twenty are kept on a diet with a definite amount of
the standard •

.This is continued for three days, and
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blood clotting_time is determined on the fourth day.
·The dose level of the unknown w�ch produces the same
average clotting time as the standard is determined,
and the potency of the unknown sample is calculated in
vitamin K units per gram.
Snell and Butt (92) in the A. M. A• Council of
Pharmacy report on vitamin Kin December, 1939 say that
there is no complete agreement among investigators as
to the best definition of a unit or method of ass�y.

The council is of the opinion that it is best not to

arbitratily establish a unit until more exact and final
knowledge of the chemistry of the vitamin is worked out.

17.
�HYSICAL AND CHEMICAL PROPERTIES
OF VITAMIN K
In studying the chemistry of vitamin K we must go
back to the early work of Dam and his coworkers.

In his

1929 article (29) he pointed-out that the substance was
probably not a sterol and was not present in cod liver
oil.

By 1934 and in 1935 he (31) (32) listed common sub-

·stances that contained the factor and reported that it is

a

fat soluble substance that resembles vitamin E chemic

ally but is not found in wheat- erm oil.

The most po

tent source tested was the easily soluble non-sterol frac
tion of the unsaponifiable matter of fractionated hog li
ver fat.

It is a heat stable substance.

Extracts of alfalfa and putrified fish meal were

'

used as sources of the vitamin and gradually pu,_rified
during the next three years.

In July 1937 Almquist (3)

reported the i_solation of crystals with antihemorrhagic
activity eight times greater than that of ordinary alfal
fa extracts.

This same year Almquist (4) outlined a me

thod of extraction and purification of the antihemorrha
gic vitamin from alfalfa.

A hexane extraction is made

and then separated three times by boiling with absolute
.

.

methyl alcohol.

The alcohol sol�tion is then concentra-

ted and stored in a centrifuge bottle at

o•c.

for several

days then centrifuged and the ·liquid poured off.

The
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precipitate is then purified several times and.mole
cular distillation is then done.
Klose in 1938 (58) indicated that the properties of
vitamin K were consistent with those of a complex unsatu
rated hydrocarbon.

He noted that activity of the vitamin

is destroyed by oxidizing agents, strong acids, aluminum
chloride, and several agents that have the ability to
add across the ethylene linkage; but it is not easily
affected by peducing·agents.

Thayer and Doisy (95) of

St. Louis also in 1938 reported the isolation of a cry
stalline compound with vitamin K activity.

This same

year Lichtman and Chambers (60) obtained antihemorrhagic
effects by injection of sterol extracts of mammalian
liver.

In March 1939 Almquist (7) prepared a choleic

acid derivative of the vitamin which is a yellow cry
stalline compound with a melting point of l86 ° C.

Vit

amin K can be separated from this as a viscous, slightly
pigmented oil that bears no relation to the crystalline.
compounds described by Almquist and Klose.

The prepar

ation is a compound of vitamin K and an excess of deo
xycholic acid which is active on ch�cks and probably
contains about 10% pure vitamin K.

The antihemorrhagic

activity of this choleic acid'derivative, was tested by
Cohn and Schmidt {27) and found to be very effective.
Riegel (80) and others also described a physiochemical
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method 0£ concentration of vitamin K from alfalfa.
Dam (38) and his collaborators have prepared in
1939 by a process of molecular distillation and chroma
tographic methods a constant product of high purity
which they believe to be pure vitamin K.

The material

is a clear yellow oil that contains carbon, hydrogen,
and oxygen, but no nitrogen.

The substance is extremely

potent on biologic assay.
In May, 1939, McKee (64) and his associates reported
the isolation of vitamin K1 from alfalfa as a light ye
llowish oil which changes into a beautiful crystalline

structure on cooling of an acetone or alcohol solution,
several preparations were obtained with a �gh vitamin
K potency.

Vitamin K 2 was purified from putrified sar

dine meal as a light yellow crystalline solid wit� a
melting point of 50.5° - 52 ° C.

By studying the absorp

tion spectra after hydrogenation of the substance and
exposure to light it is indicated that it contains a
quinoid structure.

Binkley (14) confirmed this work

in studies of the acetates of dihydro vitamins K1 and K2·
In July 1939, Almquist and Klose (9) showed that

phthiocol (2-methyl-3-hydroxy-1,4-naphthoquinone) pos
sesses physical and chemical properties similar to pure
vitamin K.

It is effective in preventing hemorrhagic

diathesis in chicks subsisting on a vitamin K deficient
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They point\,

diet when gLven in 20 mg. per kilo of diet.

out that phthiocol may be the simplest member of a ser
ies of antihemorrhagic substances.

They showed (10)

that the activity of phthiocol lies somewhere between
that of methyl-naphthoquinone and hydroxy-naphthoquinone.
The methyl group is functionally important while the h!
droxyl group seems to'reduce activity.

They agree that

the activity of phthiocol is lower than the more complex
form of vitamin K occurring in alfalfa, but this lower
activity is more than compensated for by the low cost
of preparation and convenience of administration.

Phthio

col was first isolated in 1933 by Anderson and Newman (11)
as one of the pigments of the tubercle bacillus.

It is

a yellow crystailine pigment isolated from the acetone
Its rea

soluble fat of the human tubercle bacillus.

ctions ., pro_perties, and derivatives indicate that it
is 2-methyl-3-hydroxy-1,4-naphthoquinone.

Its synthesis

has been described by these same workers {66).

In

September 1939, Fernholz and Ansbacher (42) re

ported that the antihemorrhagic activity of phthiocol
is not due to impurities in the preparation.

They also

reported the marked curative effect of 2-methyl-1,4naphthoquinone, which they found nearly as potent as
vitamin K (13).
In September 1939 Binkley (15) reported the is-
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olation....of K1 from alfalfa concentrates.

The vitamin

was adsorbed onto decalso and perm.utit and darco; it

was then obtained as an oil which was changed to the
crrstalline diacetate for analysis.

This had a con

stant sharp melting point and could be reconverted into
the original oil by hydrolysis.

The oil showed a vita

min K potency twice that of the diacetate.

He believes

that the oil prepared by Dam (38) is only about 50%
pure vitamin K and that Almquist's choleic acid deri
vative is merely an adsorption on choleic acid of im
pure concentrates.
At this same time Binkley (16) reported confirm
ation of the structural formula by synthesis which was
easily accomplished by the method of Claisen for direct
carbon alkylation of phenols.

The reaction of phytyl

bromide with a benzene suspension of the monosodium
salt of 2-methyl-1,4-naphthoquinone produced the hydro
quinone of the vitamin which was oxidized by the air to
the quinone.

This was purified by chromatographic ad

sorption and by vacuum distillation and was then sub
jected to reductive acetylation.
thus obtained.

The diacetate was

Fieser (44) also described a method of

partial_ synthesis of vitamin K1•

Thayer and Doisy (97) and their associates in stud

ying the activity of certain nap.thoquinones suggested
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that the.. structure of vitamin K1 may be 2-ethyl-3-phytyl-

1,4-naphthoquinone.
of both K1 and K2•
same formula.

They (99} also did careful assays

MacCorquodale (62} suggested the

He \61) showed that'the purified vita

min K products are rapidly inactivated by sunlight and
strong artificial illumination.

Fieser (43} reported a

tentative formula for Ki as 2,6?-dimethyl-3-phytyl-l,4naphthoquinone; and for½ of 2,3-di-farnesyl-l,4-naph
thoquinone.
The structural formula of vitamin K1 was finally

worked out definitely and reported by MacCorquodale and
his associates (63} in .1.�ovember, 1939.

Vitamin K was

found to be a 2,3-disubstituted-a-naphthoquinone having
an unsaturated side chain.

By oxidation of the vitamin

by chromic acid, phthalic acid was formed, which demon
strated that the benzoid ring 6f the vitamin contains no
side chain.

A second acid isolated from the oxidation

products was identified as 2-methyl-1 ,4-napthoquinone-

3-acetic acid, which showed that the quinone nucleus
has a methyl group at the 2 position and that the side
chain in the 3 position has an ethylene linkage between
the 2nd and 3rd carbon atoms from the quinone ring.
These conclusions were confirmed by study of the degra
dation products of the diacetyl dihydro derivative of
of the vita.min.

The further structure of the side chain
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was determined by oxidation and ozonolysis.

The constij

tution of the vitamin was then determined by synthesis.
The synthetic compound was degraded by the same proced
ure as that used on the natural vitamin derivative and
shown to have·the same degradation product.

Further con

firmation of the quinone structure of the vitamin was re
ported by Ewing (41) who studied the ultraviolet absorp
tion spectra and found the 1,4-naphthoquinoid structure
was undoubtedly present and that the vitamins are deriv
atives of 2,3-dimethyl-naphthoquinone.

The structure of

K1 arriv�d at is:

� Cll2-Cll-9 ( CH2) 3CH( CH2) 3?H( CH2) :SfHCfl3
,
6H3
�
�H3
CH3 · CH3
Early in the study of vitamin Kit was found that
putrified fish meal offered an easily accessible supply
of a potent antihemorrhagic substance, this was report
ed by Almquist and Sto�stad (1) in 1935.
has been called vitamin

Kz

This substance

and its isolation reported by

McKee (65) and his associates in November 1939.

The put

rified commercial fish meal was extracted with iso-propyl
ether, adsoFbed on decalso and permutit, then recrystal
lized from various solvents.

It has a melting point of

53.5° - 54.5° and has a potency of about 600 units per
mg.,

It has been converted by reductive acetylation

to the diacetate with a lower potency.

Evidence shows
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that.....--the vitamin K2 is a 2,3-disubstituted naphthoqui
none with six double bonds in the side chain.

C40H5402

is the approximate st�cture although this has not been
definitely determined.
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VITAMIN KAND BLOOD COAGULATION
The knowledge of the exact mechanism of blood coag�
ulation is very incomplete, and much of it highly theo
retical.

Howell (51) states that numerous discordant

theories on coagulation exist today, and it is difficult
to determine what positive increase in knowledge has re
sulted from the work done in recent years.

The funda

mental established facts divide the process o-f coagula
tion into two chief phases or stages: (1) the formation
of thrombin from its precursors, and (2) the conversion
of fibrinogen to fibrin under the influence of thrombin.
The necessary precursors to thrombin are prothromb1n,
calcium and a tissue extract (thrombokinase, cytozyme,
thromboplastin etc. ) •
PROTHROMBIN.

Prothrombin is a component of the

plasma protein, according to Snell (89) and others,
known physiologically by its action to form thrombin;
aside from this fact and its constant association with
plasma globulin, little is known of its chemical and
physical properties.

t present it is best regarded

as a physiological complex rather than as a definite
chemical substance.

Kugelmass of Yale (59) believes

that the lipoid structures of the endothelial system
of bone marrow and liver utilize vitamin Kto form and
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liberate prothrombin into the blood and lymph streams.
Obviously any functional disorder of these tissues (prin
cipally the liver) may interfere with or arrest the form
ation of prothrombin and lead to the development of hem9rrhagic manifestations due to the prothrombin deficiency.
Dam (33) points out that prothrombin has the characteris�
tics of a protein.

He has not decided whether vitamin K

is a prosthetic group of �rothrombin or acts in another
way eg. by stimulating certain cells to produce or lib
erate prothrombin.
In 1937 Smith (86) and his associates at the Univ
ersity of Iowa in studying the effect of chloroform in
toxication on the liver reported that the bleeding ten
dency in acute chloroform intoxication is due to defic
iency in both plasma fibrinogen, and plasma prothrombin.
If the disorder is mild no bleeding occurs.

However the

prothrombin falls to rather low levels although the fi
brinogen falls only moderately.

In the experimental ani

mals a bleeding tendency could be produced by giving
small repeated doses of chloroform.

In such cases the

hemorrhagic tendency is due to a deficiency of prothrom
bin alone and the fibrinogen level is unaffected.

The

relation of liver injury to plasma prothrombin level in
dicates that the liver is concerned in the manufacture
of prothrombin.

Prothrombin formation is more easily
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interfered with than is the fibrinogen formation.
Warren and Rhoads (106) demonstrated the hepatic
.origin of prothrombin in their experiments on hepatec
tomized dogs.

All dogs showed a marked drop in plasma

prothrombin in a few hours after hepatectomy in contrast
to a time of two to three months in cases of bile fis
tula dogs.
ogen.

There was also a moderate decline in fibrin

The prothrombin drop could not be accounted for

on the basis of hemorrhage, anesthesia, blood dilution
or laparotomy, thus showing that the liver is essential
for prothrombin formation in the dog.
Quick (75) states that prothrombin deficiency is
an important cause of defective and prolonged blood coa
gulation.

A wide margin of safety, however, allows nearly

80% of the prothrombin of human blood to be lost before
serious hemorrhage occurs.

Experimentally it has been

demonstrated that prothrombin can be reduced by depri
vation of vitamin K, by a toxin such as occurs in spoiled
sweet clover hay, and by inj�ry to the liver.

In all

types of prothrombin deficiency, blood transfusion is
a prompt therapeutic means of s�opping bleeding, since
sufficient prothrombin is supplied to assure normal co
agulation 6 but its beneficial action is only tempor�ry.
Permanent cure depends on restoration of normal hepatic
functi�n and normal prothrombin levels.
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THROMBOPLASTIN.

�uick (73) in 1936 discussed the

various properties of thromboplastin or tissue extract.
He states that Howell believes 'that thromboplastin mere
ly neutralizes antiprothrombin, a substance occurring
normally in the blood which is combined with prothrom
bin, and which when removed allows the latter to react
directly with calcium whereby thrombin results.

Throm

boplastin greatly accelerates the speed of clotting;
since it is fairly certain that clotting is proportion
al to the concentration of thrombin, it can be concluded
that thromboplastin increases the rate of thrombin forma
tion.

Quick observed that when oxalated plasma is mixed

with an active preparation of thromboplastin and recalci
fied with an optimal amount of calcium, a constant clot
ting time was obtained which could not be further short
ened by addition of thromboplastin.

These conditions

leave prothrombin as the only variable irrespective of
the mechanism of thrombin formation; thus it follows
that clotti�g time must be dependent on prothrombin con
centration.

This is the theory of coagulation that forms

the basis of the Quick Prothrombin time test.
Chemically th�omboplastin is a complex in which ce
phalin is a part.

It is prepared as an aqueous emulsion

of rabbit brain, lungs, and thy.mus.

Brain is the best

source "because it is easiest to free from blood.

The

, dried, ground tissue is extracted with .85% saline, heat
ed at 60'C. for fifteen minutes to inactivate thrombin
and prothrombin, and then the solid material is centri
f-u.ged out.

In

testing the properties of the thromboplastin ex

tract it was found that if increasing amounts were used,
a minimum clotting time was reached.

Quick also showed

that the thromboplastin failed to clot purified fibrino
gen or plasma from which the·prothrombin had been removed
by aluminum hydroxide cream.

On heating the extracts,

throm�plastic activity decreased with increasing temper
ature.

Distinct differences were found in the thrombo

plastic activity of tissue extracts from various common
laboratory animals, as well as a difference in response·
in these animals to the thromboplastin.

Thromboplastin

may be to some extent species specific.

In humans, the

less active response to thromboplastin appears to be due
to the smaller concentration of prothrombin than is present in the dog and rabbit.
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PROTHROMBIN DETERMINATIONS
Tests for Vitamin K Deficiency
Two basic methods have been developed for determin
ing the prothrombin in the blood·.

Measurements of pro

thrombin time and prothrombin co�centration are used as
laboratory indices of adequacy or deficiency of vitamin
K.

Both methods are indirect and therefore open to crit

icism.

The methods have been modified by various workers.

For a working outline on the process of coagulation
most authors use the simple equations:
I.

Prothrombin ..: Thromboplastin + Calcium= Thrombin.

11. Fibrinogen + Thrombin = Fibrin.
Quick developed a prothrombin time test in 1935 (72) ·
which was slightly revised in 1936 {73).
the procedure as follows:

He outlines

Under special precautions to

avoid trauma, 9 cc. of blood is rapidly withdrawn into
a syringe containing 1 cc. of 0.1 N. sodium oxalate.
The necessit

of preventing the formation of thrombin

must be stressed; speed in taking the blood, and prompt
ness and thoroughness in mixing it with the oxalate are
of the utmost importance.
after it is taken.

Blood is centrifuged soon

In a small test tube, o.l cc. of

plasma is mixed with o.l cc. of a freshly prepared stand·ardized thromboplastin emulsion and o.l cc. of .025 N.
calcium chloride is added.

The tube is immediately put
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in a water bath maintained at 37 ° c. and the exact time
for the formation of a solid clot is noted.

By this me

thod normal prothrombin time values are between 20 and
30 seconds.

Some modification of Q,uick's prothrombin

test is the most commonly used method in the various
clinics in America and Europe.
The Quick Prothrombin time test has been simpli
fied by Smith (87) and his associates at Iowa to the
"Bedside Test" describe.d below.

Venous blood is taken

from the patient and placed in a tube with an excess of
thromboplastin.

The time taken for this to clot is meas

ured in seconds and compared with the time taken for the
clotting of normal blood treated with the same reagent.
An unst�dardized preparation of thromboplastin is pre
pared from brain or lung tissue, 10 grams of ground tis
sue being extracted by 10 cc. of normal saline for two
hours and stored under refrigeration.

To perform the

test O.l cc. of thromboplastin is placed in a tube and
0.7 cc. of freshly drawn patient's blood is added to it.
The tube is inverted once immediately, and then tilted
every few seconds to determine the time·of clotting.
similar procedure is c�rried out on normal blood as a
control.

Only in this way is it possible to use un

standardized thromboplastin.

The normal must clot be

tween 25 and 60 seconds or the thromboplastin is not

A
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The clotting activity, in percent of normal,
is given by the formula:
Clotting time of normal
x 100•
Cl0tting Activit
Y = c!otting time of unknown
Values below 100% indicate a bleeding tendency and hemor-

adequate.

rhage will occur when the prothrombin level falls to 30% 50% of normal.
Warner (104) in 1936 pointed out that �uick's pro
thrombin determination involves the time of two reactions:
{l) prothrombin conversion to thrombin and (2) thrombin
plus fibrinogen to fibrin.

The uncontrolled summation

of these two reactions gives a clotting time which is
difficult to interpret in terms of prothrombin concen
tration.

Warner separates the two phases and uses only

the time �equired for the second phase as a measure of
prothrombin in his quantitative titration method.

Pro

thrombin is transformed to thrombin in a preliminary step;
then the thrombin may be titrated by means of a serial di
lution technique.

The dilution causes the antithrombin to

be ineffective in clotting.
Reagents used are: (1) oxalated saline, (2) tissue
extract (thromboplastin from dog lung), (3) oxalated plas
ma, (4) fibrinogen (from dog plasma), (5) calcium, (6)
heprain.

Steps in the determination are:

(1) isotonic

oxalate is added to the blood sample to prevent clotting,
(2) freshly prepared thrombin is added to defribinate the
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plasma, (3) clot forms and is allowed to st��d fifteen
minutes, (4) fibrin is rolled out, (5) the expressed flu
id containing prothrombin is dil�ted 1-20, 1-40, 1-80
with oxalated saline (6) these solutions are tested with
fibrinogen for the presence of thrombin (7) the test for
prothrombin - mix three parts of each dilution with three
parts of calcium and three parts of tissue extract.
plasma dilutions are then 1-149, 1-243, 1-297.

The

Tubes

are incubated and it is noted which dilution clots near
est to 15 seconds.

If 1-223 dilution clotted in 15 sec

onds the Prothrombin Unit Concentration in the undiluted
plasma was 223.

This method is highly technical and is

therefore not used in most clinics.
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C�INIC.,r, APPLICATIONS OF VITAMIN K
GENERAL THERAPEUTIC CONSIDERATIONS
The experimental work cited earlier in this paper
shows that vitamin K is a substance whose presence is
necessary in the body for the maintenance of normal plas
ma prothrombin level.

Thus if in a certain disease con

dition the pat�ent is found to have a hypO!)rothrombin
emia it can be assumed that there is a vitamin K defic
iency in the system, or that the liver is so damaged that
its capacity for the production of prothrombin is reduced.
In general it may be said that vitamin K therapy is
indicated in any case in which there is an increased pro
thrombin time or a decrease in plasma prothrombin concen
tration or hypoprothrombinemia.
Clark {26) and his associates at Mayo Clinic point
out that the maintenance of normal prothrombin level de
pends on several factors:

(1) the diet must contain the

antihemorrhagic factor; (2) bile of normal composition
must be present in the intestinal tract; (3) the proper
digestion of fat is necessary; (4) a sufficient amount
of normal intestinal mucosa for absorption of the anti
hemorrhagic substance is required ; and (5) a physiolog
ically active liver is essential for performing adequate
ly the synthesis of prothrombin.

Absence or deficiency
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of any of these requirements of sufficiently long dura
tion or severity may result in prothrombin deficiency;
therefore the diseases in which hemorrhagic diathesis
could occur can be determined theoretically and then
checked clinically for prothrombin deficiency or hypopro
thrombinem.ia.
Snell and Butt (90), (92), writing for the A. M. ·A.
Council on Pharmacy in their preliminary reports on vit
amin K, outline the important clinical and therapeutic
considerations to be kept in mind.

The main causes of

hypoprothrombinemia are: (1) Diet deficient in vitamin

K; (2) newborn infants - cause of low prothrombin un
known; (3) Inadequate intestinal absorption which may
be due to a lack of bile in the intestine from obstruc
tion of any kind to the bile ducts, or to intestinal le
sions including short circuiting surgical procedures,
intestinal obstruction, severe diarrhea, ulcerative co
litis, sprue, or celiac disease; (4) Injury to the liver
parenchJDI&. as in chloroform poisoning, extirpation, cir
rhosis, atrophy, acute and chronic hepatitis.

This last

group with the liver damage may not respond to the vita
min K therapy, as the ability of the liver to use the
vitamin in the synthe�is of the prothrombin is an im
portant factor.
The clinicians should select and become familiar
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with one of the simpler methods of prothrombin determin
ation.

It should be remembered that theoretically the

use of vitamin K is without benefit in those conditions,
hemorrhagic or otherwise, that have normal prothrombin
values.
As to methods of administering the preparations,
most workers in America have found the oral route the
best since it is simpler and results are more rapid and
more stri�ing.

However, Snell (90) reports that Dam and

his co-workers recommend the intramuscular and even intra
venous route, and he has checked their methods and found
them satisfactory and possibly best in certain patients
who may have a poor intestinal absorption surface.
Various preparations containing the vitamin or a
related antihemorrhagic factor are being used by the dif
ferent clinicians ana as yet no standard or best prepara
tion has been discoverea.

It is hoped that before long

a standard and inexpensive synthetic vitamin K prepara
tion will be abailable.
VITA!I� K THERAPY IN JAUNDICED PATIENTS
The principle clinical use of vitamin K to date has
been in cases of obstructive jaundice.

Until Quick (72)

in 1935 determined that the cause of the bleeding tenden
cy in jaundice is due to a prothrombin deficiency, little
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progress had been made in regard to treating or prevent
ing this dangerous complication of surgery in the jaun
diced patient.

Judd (56) in 1935 and others have reviews

of all the literature on the bleeding tendency in jaundice
with the various theories of its origin, but they come to
no definite conclusion as to the mechanism involved.

He

recommends the use of oxygen and blood transfusion with
routine pre-operative and post-operative care of the gallbladder patients.

Ivy (54.) determined that the calcium

level is usually normal and is not important in the hem
orrhagic conditions.
to be a factor.

Platelet deficiency does not seem

Quick (72) and others have pointed out

that plasma fibrinogen is usually at a normal level of
In January 1938 Warner (105) and his associates at
the University of Iowa reported the first use of vitamin
Kin humans.

They noted that the jaundiced patients that

showed no bleeding tendency have a prothrombin level above
50% of norm.al, but that in cases of below 35% bleedi_ng is
often encountered.· In cases of biliary fistula they also
noted a low prothrombin, and with restoration of bile to
the intestine the bleeding cea�es.

They found that feed

ing alfalfa extract rich in vitamin K, in addition to bile,
they obtained a more rapid return of prothrombin to normal
levels.

Quick (75) made his first report of the success-
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ful use of vitamin K concentrates and bile salts in jaun
diced patients in May 1938.

In June Brinkhous (18) and

his associates presented a series of 27 cases of obstruc
tive jaundice.

In most of these the plasma prot�ombin

was definitely below normal with six showing a marked
bleeding tendency.

The amount of prothrombin lowering

is not dependent on the intensity or the duration of the
jaundice.

They used a fat soluble extract of alfalfa

with various doses being administered, and in all cases
there was a cessation of bleeding associated with an in
crease in pro�hrombin.
Snell,,Butt, C lark, and others at the Mayo clinic
have reported similar successful results in the preven
tion ·of hemorrhage i
, n jaundiced patients ., (88), (21) ., (26).
Their earliest reports were in February 1938.

At this

time they were using doses of 200 mg. daily of Abbott's
alfalfa concentrate mixed with human bile and pineapple
juice and given orally before meals.
that vitaminK

They determined

is not present in human bile.

If bile

is given with a normal diet there will be some elevation
of prothrombin time.

However if vitamin K is given alone

(without bile) there is no increase in prothrombin.

How

ever if both are given together to the deficient-patient
with hemorrhagic tendency there will usually be a marked
fall

in prothrombin time within 24 hours.• Snell (91)
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later pointed out that in some cases that do not respond
to the vitamin K therapy there is a hepatic insufficiency
which is thought to be due to anatomic injury to the liv
er with suppression of certain of.its important physio
logical functions.

In a later Mayo clinic report of Butt

(22) in 1938 it was reported that they were getting con
tinually

ood results with the use of the vitamin in the

patients with obstructive jaundice by oral administration
but were not having much success with intramuscular admin
istration.
Butt (23) and his associates reported in detail a
series or 127 cases of jaundice of different types that
received vitamin K, and the results were highly success
Me

ful in curing and preventing hemorrhagic conditions.
thods of administration and dosage were discussed.

In

August 1939 Butt (24) reported that he and his associates
had administered synthetic phthiocol to ten patients show
ing hypoprothrombinemia • . In each case the prothrombin
clotting tire was decreased to within normal limits, and
in one case hemorrhage was controlled.

No untoward re

actions were noted following the use of phthio.col.

The

best results were obtained with oral· doses of 100 mg.
of the phthiocol.
In December 1939

tewart

and Rourke (94), following

an earlier article (93) in April, reported their observa-
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tions on the jaundiced patients at Massachusetts General
hospital that had been seen during the year.

They con

clude that the prothrombin deficiency in obstructive
jaundice depends on such factors as the duration of the
jaundice, degree of obstruction, infection, avitaminosis,
and malnutrition.

The response to administration of vi

tamin� choleic acid mixture is immediate except in cases
with rapicily progressing liver damage.

Massive patholog

ic bleeding may occur when the prothrombin level falls
below 40% of normal.

Besides the use of the vitamin K

in treating the prothrombin deficiency, they report it
is a lso important to give dextrose and proper fluids and
do an early decompr,ession of the biliary tract.

In gen

eral the longer the duration of the jaundice the greater
the liver damage and the lower the prothrombin concentra
tion.

There is a moderate prothrombin reduction three

to four days after obstruction begins.

They suggest

that further studies may indicate that prothrombin de
pres•sion will be one of the best liver function tests.
In regard to the question of causing an abnormally high
prothrQmbin with patholo5 1c increase in clotting tenden
cy, there seems to be a tendency for prothrombin to be
stabilized near normal during therapy.
· These same workers noted that there is an immediate
reducti.on of prothrombin or 20% - 30% directly following
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surgery.

This probably depends on the blood loss, anox

emia, effect of anesthetic, and cessation of vitamin K
intake.

The post-operative drop tends to increase dur

ing the first four days.

This shows the importance of

giving vitamin K as early as possible post-operatively.
Butt (25) in August 1939 outlined in detail the pre
and.post-operative treatment of jaundiced patients used
at the Mayo Clinic.

This is the same treatment as re

ported in February 1940 by Walters (103) of the Mayo Cli
nic surgical staff, and in general this forms the basis
of the routine treatment used in most institutions in
this country and in Europe.
The aims of the treatment are:

(1) restoration of

the patency of the biliary passages, (2) protection of
th.e 11 ver parenchyma, by high carbohydrate diet and in
travenous glucose, and (3) prevention and control of
hemorrhage.
In general the causes of obstruction are {l) neo
plasm of the pancreas, ampulla of Vater, biliary pas- �ages, and gall bladder; (2) pos�-operative stricture
of the· common duct; and (3) stone in the common duct.
For routine pre-operative care the jaundiced patients
are divided into three groups:

(I) Those with normal pro

thrombin clotting time; (II) Those who have a prolonged
prothrombin time but not active bleeding;

(III) Those
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who have a prolonged prothrombin time and active bleeding.
Group I are given prophylactic treatment for two to
five days before surgery.

The patient is given two to

six gelatin capsules containing approximatel·y 200 mg. of
alfalfa concentrate together with one to four grams of
animal bile salts.

This dose is usually adequate and

may be given orally or by duodenal tube.
The patients in group II show a prothrombin clotting
time of 30 - 50 seconds.

They usually respond to the pro

phylactic treatment listed above; however, if the clotting

time is longer than 45 - 50 seconds it is thought advis
able to administer the vitamin K concentrate and the bile
salts either through a duodenal tube or through a T-tube
after operation.

In such in'stances 2 - 4 grams of water

soluble bile salts are dissolved in 250 - 500 cc. of warm
physiological saline or tap water.

1 - 2 grams of alfal

fa concentrate of vitamin K is added to the solution and
it is kept warm and mixed during administration.

It is

best Adm1ni$tered slowly by the drip method allowing
30 - 60 minutes for the full dose to be taken.

One such

dose will usually bring the prothrombin time to normal
and only exceptionall

is it necessary to repeat the dose.

When these large doses are used, the prothrombin time is
usually norm.al or markedly decreased in six to twelve
hours.
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In group III cases which show active bleeding, the
clotted blood must first be removed by lavage before ad
equate absorption can take place.

Transfusion is often

necessary, but blood from "blood banks" should not be
used as it is already low in prothrombin; so fresh blood
should be used to get a temporary prothrombin increase.
In the meantime, vitamin K is given by duodenal tube,
T-tube or hypodermically.
Rhoads and Fliegelman (79) in February 1940 have re
ported on the use of a synthetic vitamin K substitute.
They used the simple 2-methyl-1,4-naphthoquinone in ten
patients .with a demonstrated prothrombin deficiency.

All

but one case responded satisfactorily to doses of 1 - 4
mg. per day.

Hemorrhage was completely controlled.

They

report that this is the most potent agent so far that has
been used clinically.

No toxic effects were noted.

The

advantages of this preparation are its high potency, low
cost, and ease of standardization, and lack of apparent
toxic effects.
Various other workers have reported on the succ·ess
ful use of vitamin Kand bile salts in the prevention
and control of hemorrhagic diathesis in obstructive jaun
dice.

Townsend and Mills (100) of Canada present a re

view of ten cases.

Illingworth (53) of the Edinburgh

hospitals has results that substantiate those of the

44.
workers in this country.

Greene and Hotz (48) present

a practical discussion of the subject.

Olson (69) and

Menzel (70) report on the successful use of vitamin K
concentrates.

Rhoads (78} reports the successful use

of cerophyl as a source of vitamin Kin cases of obstruc
tive jaundice.
At the present time clinicians everywhere are find
ing and reporting that vitamin - is a valuable therapeu
tic agent in surgical jaundiced patients.

It is being

used very successfully both as a prophylactic against
and directly in controlling hemorrhagic diathesis in
these patients.
VITAMIN K AND PROT=- - IN IN INFANTS AND NEWBORN
An.other possible valuable clinical application of
vitamin K seems to be indicated in the pioneer work of
several investigators in regard to the prothrombin le
vels in normal inf'ants and in those showing bleeding ten
dencies.

In 1937 Brinkhaus (17) reported that the plasma

prothrombin level in newborn infants, normal and at term,
varies between 14
adult.

and 39% of that shown by the normal

It rises gradually after birth reaching the adult

level at about the end of the first year.

He reported

one case of hemorrhagic disease ·of the newborn with a
plasma prothrombin level of less than 5% and a normal
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level of fibrinogen that responded promptly to intraven
ous transfusion with maintenance of a normal plasma pro
thrombin level.
In March 1939 Waddell (101) and his associates at
the University of Virginia reported two cases of infants
that showed an abnormally high prothrombin time that was
strikingly reduced by the oral administration of vitamin
K concentrate.

Hemorrhagic signs were completely relieved.

In April 1939 Quick and Grossman (76) contradicted
Brinkhous' earlier report by saying that the prothrombin
concentration in normal infants three to seven days old
is essentially the same as that in normal adult blood.
addell and Guerry (102) in June 1939 said that they
believed vitamin K might be effective in raising the pro
thrombin content of newborn infants' blood and thereby'
prevent both spontaneous hemorrhage and that instituted
by the trauma of labor.

It is postulated that birth

trauma may be mi�zed by administering this substance
to the mother either before or shortly after the onset of
labor.
In July 1939 Hellman and Shettles (50) of Johns
Hopkins Hospital reported on their prothrombin studies
in normal and premature infants.

They found that the

average plasma prothrombin level in eighteen mothers
was 102.5 units and in nineteen full term newborn in-
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fants it was 22.2 units.

The average prothrombin: level

in eight mothers and nine premature infants was 126 and
8.3 units respectively.

They believed·that these studies

indicate that these extremely low infant prothromqin le
vels can be raised by feeding vitamin K to the mot�er prior
to delivery or directly to the infant after birth.

They

think that the low prothrombin level may be an important
factor in cerebral hemorrhage in the newborn.

In

January 1940 Quick and Grossman (77) presented

-an outstanding discussion on the nature of the hemorrhagic
disease of the newborn.

They report that the prothrombin

concentration in inf'ant•s blood is nearly the same level
at birth as that of the adult.

It often drops rather sud

denly during the f irst few days of life but is usually re
turned promptly and s ontaneously to normal.

They suggest

that the prothrombin recovery may be due to the establish
ment of the bacterial �!ora of the intestine and that this
initiates the synthesis of vitamin

which becomes avail

able to the organism of the infant for the production of
prothrombin.

The hypothesis is presented that the cause

of hemorrhagic disease of the newborn is due to a delayed
restoration of the prothrombin level.

The disease is de

fined as one which is clinically recognized by internal
or external bleeding; it is characterized by an exceed
ingly low prothrombin concentration in the blood; it is
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It is promptly

usually self-limited but may be fatal.

cured by the administration of vitamin K.

They quote

Nygaard (68) who reports recently that the infant's pro
thrombin level is normal at birth but begins to drop dur
ing the second half of the first day.

The use of vitamin

K will prevent this fall in prbthrombin.
There is still considerable disagreement in reports
of the prothrombin levels in newborn infants.

Katsuji

and Poncher (57) in March 1940 determined the prnthrombin
levels in 173 infants during the first four weeks of life
by a modification of Quick 1 s method.

The average time of

100 mature infants was 43.2 seconds on the first day of
l�fe, gradually shortening as the infant grew older.
the tent

By

day the average time was 25 seconds. ·The av

erage prothrombin time in 73 premature infants was 46.5
on the day of birth and showed a greater degree of flue�
tuation on subsequent days than that of the mature babies.
No correlation is apparent between the degree of infant's
maturity and the prothrombin clotting time at least on
the day of birth.

They believe that the low prothrombin

level of the blood of newborn infants satisfactorily ex
plains the pathogenesis of hemorrhagic disease of the new
born.

While in some cases of intracranial hemorrhage

birth trauma was the precipitating factor, the severity
of the bleeding was apparently induced by a lowering of
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the prothrombin level of the infant's blood.

In quoting

the unpublished work of Norris and Rush (76) it is re
ported that prothrombin values of maternal blood at de
livery are above normal and those of babies about 75% of
normal.

On repeating the determinations seven to fourteen

days after delivery they noted a slight increase in the
prothrombin values of the baby's blood while there are
no significant changes in the mother's.blood.
The uncompleted work of Bohlender at the University
of

ebraska indicates that the prothrombin time at birth

is only slightly higher than that of the mother's blood,
but on subsequent days there tends to be an increased
prothrombin time followed by a gradual return toward
normal levels.

Tests are also being made ·on the effect

on the prothrombin level in the baby from feeding vita
min

a to the mother before labor. Various methods of

administration are being tried.

VITAMIN� AND PROTHROMBIN IN MISCELLANEOUS CONDITIONS
Snell (91) and his associates at Mayo Clinic have re
ported on the use of vitamin Kin cases of hemophilia,
menorrhagia, and essential hematuria and in no instance
was the normal prothrombin time altered or the tendency
to bleed affected appreciably.
Zuckerman {108) found that a hemorrhagic tendency
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was produced in a human with a total external biliary
fistula and a low fat diet omitting oral bile feeding.
The bleeding was alleviated by the use of both vitamin
Kand bile but not by the use of either one alone.
Scanlon (82} at Cornell University reported that
patients with thrombocytopenic purpura and hemophilia
have normal prothrombin values and receive no relief
from vitamin K.

Three cases of leukemia showed a slightly

lowered prothrombin.

In cases of Laennec 1 s cirrhosis the

protbrombin level may be markedly reduced, but evidence
indicates that the reduction is due to defective hepatic
function and not vitamin-K deficiency.
Burch and Mead (19} at the University of Minnesota
report the apparent successful use of vitamin Kin one
case of idiopathic hemorrhagic retinitis.

The prothrom

bin time was not determined, but the coagulation time
was four minutes.

This work has not been confirmed by

other workers.
The use of vitamin Kin cases of non-tropical sprue
has been report�d by Engel (40) and Hult (52) in Europe,
but the articles describing the results are not locally
available .
Late in 1939 Kugelmass (59) of Yale reported on the
use of vitamin Kin Pseudohemophilia Hepatica of child
hood.

This rare syndrome accompanies acute destruction
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of liver tissue in infectious invasions such as Weil's
disease, syphillis, acute yellow atrophy, or chemical
poisons such as arsenic, chloroform, phosphorus, or sul
fanilamide.

The bleeding in each of these disturbances

is due to a decreased production of prothrombin and fi
brinogen in the liver with a resultant diminution of con
centration in the plasma, especially of the prothrombin,
with resulting prolonged clotting time.

The vitamin has

been �ound to be of value in this condition with a report
of its successful use in a case of infective jaundi.c e and
a case of hemolytic anemia resulting from sulfanilamide
intox1.cation.
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smmARY AND CONCLUSION
The pa1.nstak1ng work of many laboratory techni
cians and clinicians during the past decade has par
tially unravelled the fascinating story of an acces
sory food substance called vitamin K.

The vitamin is

a fat sol·ble, complex hydrocarbon which has been pur
ified, _ts chemical structure determined, and its syn
thesis accomplished.

It occurs naturally in such common

substances as alfalfa, milk, egg yolk, fish meal, spin
ach,

omatoes, etc.

It is probable that individuals on

iet receive an adequate supply of the vitamin.

a no

Presence of bile in the intestine is essential for the
ab� � t-on of the vitamin.

Methods of assay have been

develope� but are not well standardized at present, and
a

eneral

accepted definition of a Unit of the vitamin

has no� been found.
deficiency of this vitamin causes a hemorrhagic
tendenc

rirst noted in chicks, later in bile fistula

rats, do s, in cattle suffering from "sweet clover"
disease, and in jaundiced humans.

It has been found

that this hemorrhagic tendency is due to a decreased
plasma prothrombin concentration.

The essential re

quirements for a normal prothrombin concentration are
an adequate intake of vitamin K, presence of bile in the
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intestine, normal intestinal absorptive surface, and
a physiologically normal liver.
A deficiency of the vitamin is demonstrated clin
ically by hemorrhagic diathesis and plasma prothrombin
decrease.

Tests have been developed for determining

the prothrombin level as a means of indicating the ad
visability of vitamin K therapy.

A patient showing a

lowered prothrombin and vitamin K deficiency will usually
respond in a few hours to the oral administration of vi
tamin K and bile salts if the latter are necessary.
The chief clinical use has been in patients with
obstructive jaundice who frequently show hemorrhagic
tendencies with low plasma prothrombin levels.

In most

hospitals jaundiced patients receive routine pre-oper
ative and post-operative administration of the vitamin
and bile salts as a prophylactic measure.

It also is

used successfully in cases where hemorrhage has developed.
Studie� of the prothrombin levels in newborn in
fants indicate that there are often low prothrombin
levels especially in those showing hemorrhagic disease
of the newborn or in those developing intracranial hem
orrhage.

Administration of vitamin K is valuable in re

storing normal prothrombin levels and controlling hem
orrhage.
At present no standard preparation is available

\
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and necessary dosages have not been determined.

However

it is hoped that soon a standardized synthetic preparation of the vitamin will be available so that therapy and
research may be more standardized.
It is possible that this new substance will be found
to be of value in other hemorrhagic conditions as further
research is carried out.

However at present the physi

cian and surgeon has a new weapon in vitamin K that ap
pears to be almost specific in preventing and controlling
certain hemorrhagic conditions by raising plasma prothrom
bin levels to normal.
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